HUP9801122A3 - Osteoprotegerin - Google Patents

Osteoprotegerin

Info

Publication number
HUP9801122A3
HUP9801122A3 HU9801122A HUP9801122A HUP9801122A3 HU P9801122 A3 HUP9801122 A3 HU P9801122A3 HU 9801122 A HU9801122 A HU 9801122A HU P9801122 A HUP9801122 A HU P9801122A HU P9801122 A3 HUP9801122 A3 HU P9801122A3
Authority
HU
Hungary
Prior art keywords
osteoprotegerin
Prior art date
Application number
HU9801122A
Other languages
English (en)
Original Assignee
Amgen Inc Thousand Oaks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/577,788 external-priority patent/US6613544B1/en
Application filed by Amgen Inc Thousand Oaks filed Critical Amgen Inc Thousand Oaks
Publication of HUP9801122A2 publication Critical patent/HUP9801122A2/hu
Publication of HUP9801122A3 publication Critical patent/HUP9801122A3/hu
Publication of HU227482B1 publication Critical patent/HU227482B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
HU9801122A 1995-12-22 1996-12-20 Osteoprotegerin HU227482B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/577,788 US6613544B1 (en) 1995-12-22 1995-12-22 Osteoprotegerin
US08/706,945 US6369027B1 (en) 1995-12-22 1996-09-03 Osteoprotegerin
PCT/US1996/020621 WO1997023614A1 (en) 1995-12-22 1996-12-20 Osteoprotegerin

Publications (3)

Publication Number Publication Date
HUP9801122A2 HUP9801122A2 (hu) 1998-08-28
HUP9801122A3 true HUP9801122A3 (en) 2000-09-28
HU227482B1 HU227482B1 (en) 2011-07-28

Family

ID=27077338

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801122A HU227482B1 (en) 1995-12-22 1996-12-20 Osteoprotegerin

Country Status (31)

Country Link
US (1) US6369027B1 (hu)
EP (4) EP0784093B1 (hu)
JP (1) JP4657388B2 (hu)
KR (1) KR100463584B1 (hu)
CN (1) CN1318588C (hu)
AR (1) AR004400A1 (hu)
AT (1) ATE409745T1 (hu)
AU (1) AU710587B2 (hu)
BG (1) BG63347B1 (hu)
CA (1) CA2210467C (hu)
CZ (1) CZ292587B6 (hu)
DE (1) DE19654610A1 (hu)
DK (1) DK0784093T3 (hu)
EE (1) EE04643B1 (hu)
ES (1) ES2316152T3 (hu)
FR (1) FR2742767B1 (hu)
GB (1) GB2312899B (hu)
HK (1) HK1001526A1 (hu)
HU (1) HU227482B1 (hu)
IL (1) IL121520A (hu)
MX (1) MX9706193A (hu)
NO (1) NO973699L (hu)
NZ (2) NZ326579A (hu)
PL (1) PL187408B1 (hu)
PT (1) PT784093E (hu)
RO (1) RO121386B1 (hu)
SI (1) SI0784093T1 (hu)
SK (1) SK110797A3 (hu)
TR (1) TR199601036A2 (hu)
WO (1) WO1997023614A1 (hu)
YU (1) YU69196A (hu)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7078493B1 (en) 1995-03-15 2006-07-18 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like genes
US7005413B1 (en) 1995-12-22 2006-02-28 Amgen Inc. Combination therapy for conditions leading to bone loss
US7632922B1 (en) * 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
JPH1057071A (ja) * 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
CA2273852C (en) 1996-12-06 2009-09-29 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
CA2274987C (en) 1996-12-23 2012-01-24 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
ES2263204T5 (es) * 1997-04-15 2013-10-14 Daiichi Sankyo Company, Limited Nueva proteína y proceso para producir la misma
EP0975754B2 (en) 1997-04-16 2016-01-06 Amgen Inc., Osteoprotegerin binding proteins and their receptors
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
WO1998049305A1 (en) * 1997-05-01 1998-11-05 Amgen Inc. Chimeric opg polypeptides
AU9013998A (en) * 1997-07-21 1999-02-10 Zymogenetics Inc. Tumor necrosis factor receptor ztnfr-5
EP1019502A2 (en) * 1997-08-06 2000-07-19 Regeneron Pharmaceuticals, Inc. Human orphan receptor ntr-1
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
WO1999011790A1 (en) * 1997-09-04 1999-03-11 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-6
JP4303883B2 (ja) * 1997-09-18 2009-07-29 ジェネンテック・インコーポレーテッド ＤｃＲ３ポリペプチドというＴＮＦＲ相同体
JP4268684B2 (ja) * 1997-09-24 2009-05-27 第一三共株式会社 骨代謝異常症の診断方法
US6087555A (en) * 1997-10-15 2000-07-11 Amgen Inc. Mice lacking expression of osteoprotegerin
JPH11155420A (ja) * 1997-12-02 1999-06-15 Snow Brand Milk Prod Co Ltd トランスジェニック動物
EP1037908A2 (en) * 1997-12-16 2000-09-27 Incyte Pharmaceuticals, Inc. Human tumor necrosis factor-r2-like proteins
US6077689A (en) 1997-12-24 2000-06-20 Amgen Inc. Enhanced solubility of recombinant proteins
AU2589399A (en) * 1998-02-17 1999-08-30 Incyte Pharmaceuticals, Inc. Human short-chain tnf-receptor family protein
US6150098A (en) * 1998-02-20 2000-11-21 Amgen Inc. Methods for identifying novel secreted mammalian polypeptides
US6103472A (en) * 1998-02-20 2000-08-15 Amgen Inc. Methods and compositions for identifying novel secreted mammalian polypeptides in yeast
WO1999054360A1 (fr) 1998-04-23 1999-10-28 Ajinomoto Co., Inc. Substance possedant une activite antithrombotique et procede de detection de glycokallidine
US6790823B1 (en) * 1998-04-23 2004-09-14 Amgen Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
EP2009025B1 (en) 1998-05-14 2011-07-27 Immunex Corporation Method of inhibiting osteoclast activity
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
PL196790B1 (pl) * 1998-09-15 2008-01-31 Pharmexa As Zastosowanie zwierzęcego polipeptydu OPGL lub jego podsekwencji, lub analogu OPGL, zastosowanie fragmentu kwasu nukleinowego, zastosowanie wektora przenoszącego fragment kwasu nukleinowego, zastosowanie niepatogennej transformowanej komórki, zastosowanie kompozycji zawierającej taki fragment lub wektor, sposób identyfikacji zmodyfikowanego polipeptydu OPGL, sposób wytwarzania kompozycji immunogennej
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
ME00238B (me) 1998-10-23 2011-02-10 Kirin Amgen Inc Mimičko vezivanje dimernog trombopoitetinskog peptida za mp1 receptor sa trombopoietičkom aktivnošću
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
TW529954B (en) * 1998-10-28 2003-05-01 Sankyo Co Agent for treating abnormal bone metabolism
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
WO2000042216A2 (en) * 1999-01-18 2000-07-20 Osteometer Biotech A/S Genetic predisposition to abnormal calcification conditions
US20030007972A1 (en) * 1999-02-24 2003-01-09 Edward Tobinick Cytokine antagonists and other biologics for the treatment of bone metastases
US7259253B2 (en) * 1999-05-14 2007-08-21 Quark Biotech, Inc. Genes associated with mechanical stress, expression products therefrom, and uses thereof
AU6078500A (en) * 1999-07-09 2001-01-30 Amgen, Inc. Combination therapy for conditions leading to bone loss
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
IL130989A0 (en) * 1999-07-20 2001-01-28 Compugen Ltd Variants of alternative splicing
US6673771B1 (en) * 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
AU6946300A (en) * 1999-08-30 2001-03-26 Mayo Foundation For Medical Education And Research Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders
US20030144187A1 (en) * 1999-09-03 2003-07-31 Colin R. Dunstan Opg fusion protein compositions and methods
JP2003508491A (ja) * 1999-09-03 2003-03-04 アムジエン・インコーポレーテツド 癌および癌に関連する骨損失の予防または治療のための組成物および方法
AU2005237128B2 (en) * 1999-09-03 2008-09-11 Amgen Inc. Compositions and Methods for the Prevention or Treatment of Cancer and Bone Loss Associated with Cancer
US6808902B1 (en) * 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
MXPA02006027A (es) * 1999-12-16 2002-12-05 Amgen Inc Moleculas tipo osteoprotegerina/receptor del factor de necrosis de tumor y usos de las mismas.
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
AU2001270266B2 (en) 2000-06-28 2004-10-21 Amgen Inc. Thymic stromal lymphopoietin receptor molecules and uses thereof
US6884598B2 (en) * 2000-09-22 2005-04-26 Immunex Corporation Screening assays for agonists and antagonists of receptor activator of NF-κB
WO2002064782A2 (en) * 2001-02-09 2002-08-22 Maxygen Holdings Ltd. Rank ligand-binding polypeptides
JP4921687B2 (ja) 2001-04-03 2012-04-25 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳中の破骨細胞分化抑制因子
US20030021785A1 (en) * 2001-06-06 2003-01-30 Dougall William C. Use of rank antagonists to treat cancer
SG173211A1 (en) 2001-06-26 2011-08-29 Amgen Inc Antibodies to opgl
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
KR100427299B1 (ko) * 2001-08-10 2004-04-14 한국생명공학연구원 인체 골 재흡수 억제인자（ｈＯＰＧ）를 생산하는 재조합플라스미드 ｐＧＨＯＰＧ（ＫＣＴＣ １０１９ＢＰ）
US6800462B2 (en) * 2001-09-10 2004-10-05 Abgenomics Corporation Production of recombinant proteins in vivo and use for generating antibodies
US20030049694A1 (en) * 2001-09-10 2003-03-13 Chung-Hsiun Wu Production of fusion proteins and use for identifying binding molecules
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
JP4336467B2 (ja) * 2001-10-15 2009-09-30 株式会社林原生物化学研究所 破骨細胞形成抑制因子の産生を調節し得る物質のスクリーニング方法
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
AU2003243139B2 (en) 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
US20080249068A1 (en) * 2002-09-05 2008-10-09 Deluca Hector F Method of Extending the Dose Range of Vitamin D Compounds
US7259143B2 (en) * 2002-09-05 2007-08-21 Wisconsin Alumni Research Foundation Method of extending the dose range of vitamin D compounds
MXPA05006147A (es) 2002-12-10 2005-08-26 Schering Plough Ltd Ligando del activador del receptor de nf-kb de canino, y metodos para preparar y usar el mismo.
TWI293882B (en) 2003-03-24 2008-03-01 Sankyo Co Polymeric modifiers and pharmaceutical compositions
CA2572765C (en) 2004-07-08 2013-05-21 Amgen Inc. Compound having improved bioefficiency when administered in a multidose regimen
WO2006063390A1 (en) * 2004-12-13 2006-06-22 Evogenix Ltd Osteoprotegerin variant proteins
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JO3324B1 (ar) 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
EP2162540A2 (en) 2007-05-22 2010-03-17 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
EP3135294B1 (en) 2009-08-14 2020-06-03 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Use of il-15-il-15 receptor heterodimers to treat lymphopenia
EA032917B1 (ru) 2010-09-28 2019-08-30 Амилин Фармасьютикалс, Ллк Сконструированные полипептиды, характеризующиеся увеличенной продолжительностью действия
EP2764565B1 (en) 2011-10-05 2023-02-22 OneD Material, Inc. Silicon nanostructure active materials for lithium ion batteries and processes, compositions, components, and devices related thereto
MX357291B (es) * 2012-03-31 2018-07-04 R Pharm Cjsc Closed Joint Stock Company Composicion derivada de osteoprotegerina y su uso.
US11680101B2 (en) 2017-01-27 2023-06-20 Kymab Limited Anti-OPG antibodies
JP6550413B2 (ja) * 2017-02-24 2019-07-24 アール−ファーム・インターナショナル・リミテッド・ライアビリティ・カンパニーＲ−Ｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ， Ｌｌｃ オステオプロテゲリン由来の組成物およびその使用
CN111004318B (zh) * 2019-12-30 2022-03-04 北京博康健基因科技有限公司 rhPTH(1-34)蛋白原液的纯化方法
TW202203964A (zh) 2020-04-17 2022-02-01 小利蘭史丹佛大學董事會 用於生物醫藥調配物之聚合物賦形劑

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4710473A (en) 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
FR2640537B1 (fr) 1988-12-21 1992-02-21 Levy Guy Installation et procede utilisant l'effet laser, pour la coupe ou la vaporisation de materiaux et tissus divers
DE68925966T2 (de) 1988-12-22 1996-08-29 Kirin Amgen Inc Chemisch modifizierte granulocytenkolonie erregender faktor
WO1990014363A1 (en) 1989-05-19 1990-11-29 Amgen Inc. Metalloproteinase inhibitor
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2068389A1 (en) * 1991-05-13 1992-11-14 Masahiko Sato Method for inhibiting bone resorption
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
JP3284481B2 (ja) 1993-08-20 2002-05-20 本田技研工業株式会社 車両用油圧作動式変速機の油圧制御回路
US6268212B1 (en) 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression
JP3433495B2 (ja) 1993-12-30 2003-08-04 カシオ計算機株式会社 表示制御装置および表示制御方法
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996028546A1 (en) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor
US8615703B2 (en) 2010-06-04 2013-12-24 Micron Technology, Inc. Advanced bitwise operations and apparatus in a multi-level system with nonvolatile memory

Also Published As

Publication number Publication date
EP0784093B1 (en) 2008-10-01
RO121386B1 (ro) 2007-04-30
EP2332974A3 (en) 2012-01-11
HK1001526A1 (en) 1998-06-26
AR004400A1 (es) 1998-11-04
TR199601036A3 (hu) 1997-07-21
NZ326579A (en) 1999-01-28
CA2210467A1 (en) 1997-07-03
GB2312899A (en) 1997-11-12
IL121520A (en) 2010-11-30
JPH11503616A (ja) 1999-03-30
FR2742767B1 (fr) 2001-03-30
CZ292587B6 (cs) 2003-10-15
CA2210467C (en) 2011-02-08
GB2312899B (en) 1999-05-05
AU710587B2 (en) 1999-09-23
JP4657388B2 (ja) 2011-03-23
NO973699L (no) 1997-10-21
AU1468697A (en) 1997-07-17
DE19654610A1 (de) 1997-06-26
MX9706193A (es) 1997-11-29
EP0784093A1 (en) 1997-07-16
CN1182452A (zh) 1998-05-20
SI0784093T1 (sl) 2009-04-30
KR19980703599A (ko) 1998-12-05
PL321938A1 (en) 1998-01-05
CZ253897A3 (cs) 1999-03-17
EP2332974A2 (en) 2011-06-15
BG63347B1 (bg) 2001-10-31
DK0784093T3 (da) 2008-12-15
KR100463584B1 (ko) 2005-06-07
YU69196A (en) 1999-11-22
EP1990415A1 (en) 2008-11-12
GB9626618D0 (en) 1997-02-05
HUP9801122A2 (hu) 1998-08-28
WO1997023614A1 (en) 1997-07-03
EE9700164A (et) 1998-02-16
SK110797A3 (en) 1999-07-12
PL187408B1 (pl) 2004-07-30
BG101813A (en) 1998-09-30
NO973699D0 (no) 1997-08-12
ATE409745T1 (de) 2008-10-15
HU227482B1 (en) 2011-07-28
FR2742767A1 (fr) 1997-06-27
CN1318588C (zh) 2007-05-30
TR199601036A2 (tr) 1997-07-21
NZ332915A (en) 2000-07-28
PT784093E (pt) 2008-12-17
EP0870023A1 (en) 1998-10-14
US6369027B1 (en) 2002-04-09
EE04643B1 (et) 2006-06-15
ES2316152T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
GB2312899B (en) Osteoprotegerin
ZA9610770B (en) Osteoprotegerin.
DE69618557D1 (en) Kolbenverdichter
HUP9801128A3 (en) Fucopeptides
ZA968483B (en) Endothelin-receptor-antagonists
DE59602888D1 (en) Breitstreckaggregat
DE59602030D1 (en) Zellige polyurethan-elastomere
DE59602283D1 (en) Inchbremseinrichtung
DE59505396D1 (en) Handhobelmaschine
AP9600802A0 (en) Libricant
PL326755A1 (en) Cyclopeptolydes
DE59604506D1 (en) Rückkühlsystem
DE59600830D1 (en) Breitstrahldüse
AU1105P (en) DALESE Metrosideros excelsus
AU127800S (en) Gamesboard
AU126796S (en) Book-ends
GB9505222D0 (en) Easibutton
GB9508275D0 (en) Opto-ram
GB9503744D0 (en) Pure-air
BG99666U (en) Sun-heater
AU125849S (en) Tea - towel
GB9506322D0 (en) TR9 - biotop
AU125852S (en) Tea - towel
AU125853S (en) Tea - towel
AU126739S (en) Gamesboard

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees